J Public Health Manag Pract by Auerbach, John
The 3 Buckets of Prevention
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The US health care system is in a time of unprecedented change. The expansion of insurance 
coverage, redesign of the reimbursement systems, and growing influence of patient-centered 
medical homes and accountable care organizations all bring opportunities for those 
interested in the prevention of disease, injury, and premature death for entire communities as 
well as individual patients.1,2 It is, in short, a time when public health can come to the fore.
Public health practitioners can assist clinical providers in assuring that newly insured people 
receive services that promote health and do not simply treat illness. They can help insurers 
identify the quality measures and incentives that yield better health outcomes and control 
costs. They can provide evidence of effective interventions that were previously funded by 
public health grants but can now be brought to scale if paid for by the health care sector. And 
they can even point to ways to complement traditional health care treatment with 
community-oriented population health measures.
It is obvious that none of this will come easily. Nonetheless, at this moment—unprecedented 
in the careers of most public health practitioners, and of uncertain duration—it is critically 
important to try.
Public health practitioners need to be on the lookout for the circumstances in which their 
expertise may be of value—such as those created by the Center for Medicare & Medicaid 
Innovation’s State Innovation Model grants or its Accountable Health Communities 
initiative. Once the potential opportunities are identified, the next step is to get to the table 
where the discussions occur. But even more important, once public health practitioners get a 
seat, they must be prepared to make a positive contribution. That requires familiarity with 
and sensitivity to the needs, concerns, and goals of clinical providers and the insurance 
industry—and readiness to offer concrete and specific suggestions that fit the occasion. 
Awareness of all these factors, however, is complicated by the multiple interpretations of 
prevention (primary, secondary, tertiary) and varying definitions of population health (a 
patient panel, a payer’s covered lives, a total community).3
Rather than choosing between one approach and another, the Centers for Disease Control 
and Prevention (CDC) has developed a conceptual population health and prevention 
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framework with 3 categories—or as we have come to call them, “buckets”—of prevention 
(Figure). Each one will be needed to yield the most promising results for a population, 
regardless of whether the population is defined narrowly, as, for example, the patients in a 
medical practice, or broadly, as, for example, the residents of a state. This 3-part framework 
may be particularly useful as a way of maximizing the likelihood that clinicians, insurers, 
and public health practitioners attend to traditional office-based as well as innovative clinical 
approaches and do not neglect the community factors that have an enormous impact on 
health.
What Are These 3 Buckets?
Traditional clinical preventive interventions
These approaches involve the care provided by physicians and nurses in a doctor’s office 
during a routine one-to-one encounter. They have a strong evidence base for efficacy in 
health improvement and/or cost-effectiveness. Examples include seasonal flu vaccines, 
colonoscopies, and screening for obesity and tobacco use. While such traditional clinical 
preventive interventions have historically been reimbursed by insurers, and many are now 
even mandated for most plans by the Affordable Care Act without cost sharing, there is 
often room for improvement in their promotion and rate of adoption. Improvement can be 
achieved by various action steps by insurers (eg, increasing the weight with which various 
preventive interventions are financially incentivized as quality measures), by clinical 
practices (eg, carefully monitoring that each clinician in the practice provides them), and by 
public health practitioners (eg, designing social marketing aimed at the public and/or clinical 
providers and promoting best practices).4,5
A new effort that focuses on the patient-oriented buckets—the first 2 in this list—is the 
CDC’s 6|18 Initiative, which is designed to promote the adoption of evidence-based 
interventions by health care purchasers and payers (www.cdc.gov/sixeighteen). The name 
comes from the initial focus on 6 high-burden health conditions and 18 evidence-based 
interventions that can improve health and/or save money in a relatively short time period. 
The CDC has tapped subject matter expertise within the agency and culled public health and 
clinical research to pinpoint those clinical preventive approaches that offer some of the 
clearest and strongest evidence of effectiveness. For example, the 6|18 Initiative proposes the 
elimination of cost sharing for medications to treat hypertension and cholesterol and for 
tobacco cessation drugs, since, as research points out, even low co-pay charges for such 
drugs discourage many patients from taking them.6–9 It also high-lights the benefits of 
comprehensive reproductive care by including information about long-acting reversible 
contraception, which has proven to be highly effective in preventing unintended 
pregnancies.10–12
Innovative preventive interventions that extend care outside the clinical setting
The approaches in bucket 2 are, like the approaches in bucket 1, clinical in nature and 
patient-focused. But they include interventions that have not been historically paid for by 
fee-for-service insurance and occur outside of a doctor’s office setting—interventions that 
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have nonetheless been proven to work in a relatively short time.13 Several have been piloted 
within the public health sector with grants from governmental agencies and foundations.
An example of a bucket 2 approach grew out of epidemiologic analysis by the Camden 
Coalition of Health Providers in New Jersey. By geocoding Camden health data, Camden 
Coalition staff identified a disproportionate number of symptomatic asthmatic patients living 
in 2 buildings. In response, they designed home-based approaches to identify and reduce 
environmental triggers and provide customized, home-based preventive educational 
counseling.14–16
The 6|18 Initiative has identified a number of the interventions in this bucket as well. For 
example, it has summarized the evidence for the use of community health workers to 
provide Camden-like home-based education and trigger remediation for the families of 
children with moderate to severe asthma.17–20 In addition, it highlights the benefits of the 
use of the well-established CDC National Diabetes Prevention Program and its multisession, 
community-based, behavioral change interventions to prevent or reduce the symptoms 
associated with diabetes.21–23 Both of these are examples of extending care for individuals 
from the clinical setting to the community.
Total population or community-wide interventions
With bucket 3, the focus shifts. It includes interventions that are no longer oriented to a 
single patient or all of the patients within a practice or even all patients covered by a certain 
insurer. Rather, the target is an entire population or subpopulation usually identified by a 
geographic area. Interventions are based not in the doctor’s office but in such settings as a 
neighborhood, city, county or state.3 This bucket is the one that is most unfamiliar to the 
clinical sector but quite comfortable to the public health sector.
While public health has significant experience with such total population approaches, not all 
of them have a proven and strong evidence base. Interventions may be associated with, say, 
promoting a healthy behavior or preventing an unhealthy one—although research to confirm 
the impact may not have been conducted. In some total population interventions, the impact 
is shown to occur over the course of many years or even a generation. Such interventions 
may be a lower priority to insurers and stakeholders who are focused on a short-term return 
on investment. The longstanding Guide to Community Preventive Services (Community 
Guide) offers clear direction on which approaches have the strongest track records.
Nonetheless, some total population interventions do have a strong evidence base regarding 
improved health and/or cost within a relatively short time. For example, cigarette taxes, 
smoking ban regulations or laws, and well-designed advertising campaigns have each been 
shown to have a rapid impact on reduced cigarette use.24 And a reduction in cigarette use 
has been associated with a statistically significant decline in serious health consequences 
within 18 months.25 There is also evidence that community-wide, multifactorial, coordinated 
efforts to promote healthful eating and increased physical activity have resulted in a decline 
in the childhood risk for obesity within a few years.26 Similarly, housing policies that reduce 
environmental triggers have been shown to reduce active asthma symptoms and health 
services utilization within a few years.20,27
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Clearly, pilots are needed to prove the feasibility of financial incentives for clinicians for the 
promotion of total population health interventions. Some initial efforts are under way to link 
global payments to improvement in specific health indicators in community populations.3 
States such as Vermont and Oregon are considering total population health measures in their 
delivery system reform plans. The larger the market share of a clinical provider, the more 
likely that a community-wide intervention will be seen as being in its financial interest.
In addition to its 6|18 Initiative, CDC has also created the Community Health Improvement 
Navigator Web site (www.cdc.gov/CHInav), with information and resources that illustrate 
how the clinical sector can support evidence-based approaches with the targeted and 
strategic use of community benefits by nonprofit hospitals. Other tools in development will 
summarize the evidence for total population intervention.
Coordinated multisector initiatives that promote all 3 buckets simultaneously may result in 
the largest gains. One example of this occurred in Massachusetts after it implemented its 
health care reform initiative in 2007. The state expanded its cost-free insurance Medicaid 
coverage for tobacco cessation medications, linked patients to counselors on a Quitline, and 
promoted the increased accessibility and overall benefit of tobacco cessation interventions in 
public information campaigns. When work in each bucket was focused on a single goal, 
smoking rates plummeted.28–30
Summary
In summary, this is a critical moment in health system transformation in America. Change of 
this magnitude may not occur again in our lifetimes. Full participation of public health 
practitioners in the process will help achieve the goal of ensuring access to high-quality and 
effective clinical preventive services, both traditional and innovative, while at the same time 
working upstream to promote health and wellness in community settings. Public health 
practitioners should have at their fingertips specific, evidence-based, prevention-related 
proposals that fit multiple settings—from the doctor’s office to the insurer’s conference 
room to the neighborhood meeting to the state house.2
An optimal strategy is one in which prevention approaches span the 3 buckets—traditional 
and innovative clinical preventive as well as total population interventions.2,31,32 Each 
bucket requires its own prioritized interventions and funding sources.13 At some “tables” 
and in some settings, only 1 of the 3 buckets may be of interest to the participants. Public 
health professionals add value when they stand ready to adapt their proposals to fit the 
opportunity at hand. But ultimately, a holistic preventive strategy requires a focus on all 3 
buckets delivered in a thoughtful and coordinated manner—taking advantage of the greatly 
expanded possibilities that stand before the public health community.2,5,13
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